The PE Ratio as of December 2024 (TTM) for Acrivon Therapeutics, Inc. Common Stock (ACRV) is -2.32

According to Acrivon Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current PE Ratio is -2.32. This represents a change of -4.31% compared to the average of -2.42 of the last 4 quarters.

Acrivon Therapeutics, Inc. Common Stock (ACRV) Historical PE Ratio (quarterly & annually)

How has ACRV PE Ratio performed in the past?

The mean historical PE Ratio of Acrivon Therapeutics, Inc. Common Stock over the last ten years is -24.27. The current -2.32 PE Ratio has changed 855.76% with respect to the historical average. Over the past ten years (40 quarters), ACRV's PE Ratio was at its highest in in the December 2023 quarter at -1.43. The PE Ratio was at its lowest in in the September 2021 quarter at -24.31.

Acrivon Therapeutics, Inc. Common Stock (ACRV) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Acrivon Therapeutics, Inc. Common Stock PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acrivon Therapeutics, Inc. Common Stock (ACRV) Average PE Ratio

How has ACRV PE Ratio performed in the past?

The current PE Ratio of Acrivon Therapeutics, Inc. Common Stock (ACRV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Acrivon Therapeutics, Inc. Common Stock (ACRV) PE Ratio vs. Peers

How is ACRV’s PE Ratio compared to its peers?

Acrivon Therapeutics, Inc. Common Stock’s PE Ratio is less than Aerovate Therapeutics, Inc. (-0.88), greater than Adagene Inc. (-2.61), greater than Rezolute, Inc. (-4.42), less than AN2 Therapeutics, Inc. (-0.68), greater than Anebulo Pharmaceuticals, Inc. (-3.86), less than PMV Pharmaceuticals, Inc. (-1.46), greater than Molecular Partners AG (-2.46), greater than Mineralys Therapeutics, Inc. (-4.12), greater than AnaptysBio, Inc. (-2.52), less than Opthea Limited (-1.15),

Build a custom stock screener for Acrivon Therapeutics, Inc. Common Stock (ACRV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acrivon Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acrivon Therapeutics, Inc. Common Stock (ACRV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acrivon Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.